Felix von Coerper
Gründer bei SUNU Ventures BV
Profil
Felix von Coerper is the founder of SUNU Ventures BV, where he holds the title of Managing Partner starting in 2014.
He is currently a Director at Apic Bio, Inc. since 2019.
Mr. von Coerper previously worked as a Director at Amylyx Pharmaceuticals, Inc.
Aktive Positionen von Felix von Coerper
| Unternehmen | Position | Beginn |
|---|---|---|
SUNU Ventures BV
 SUNU Ventures BV Investment ManagersFinance SUNU Ventures BV is a venture capital firm founded in 2014 by Von Coerper felix. The firm headquartered at Amsterdam, Netherlands. | Gründer | 01.04.2014 |
Apic Bio, Inc.
 Apic Bio, Inc. Packaged SoftwareTechnology Services Apic Bio, Inc. engages in the development of treatment for neurological and liver diseases. It offers THRIVE, a platform that silences a mutant gene product and replaces a normal gene product in a single dual function vector. The company was founded by Robert H. Brown, Jr., John Reilly, and Christian Mueller in 2017 and is headquartered in North Cambridge, MA. | Direktor/Vorstandsmitglied | 08.01.2019 |
Ehemalige bekannte Positionen von Felix von Coerper
| Unternehmen | Position | Ende |
|---|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 01.12.2021 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AMYLYX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
SUNU Ventures BV
SUNU Ventures BV Investment ManagersFinance SUNU Ventures BV is a venture capital firm founded in 2014 by Von Coerper felix. The firm headquartered at Amsterdam, Netherlands. | Finance |
Apic Bio, Inc.
Apic Bio, Inc. Packaged SoftwareTechnology Services Apic Bio, Inc. engages in the development of treatment for neurological and liver diseases. It offers THRIVE, a platform that silences a mutant gene product and replaces a normal gene product in a single dual function vector. The company was founded by Robert H. Brown, Jr., John Reilly, and Christian Mueller in 2017 and is headquartered in North Cambridge, MA. | Technology Services |
